(Total Views: 517)
Posted On: 12/17/2024 9:15:31 AM
Post# of 148863
Re: HHIGambler #148734
Agree that was my take. The HIV LATCH study is interesting. Sounds like it will finally start.
“The Company will be prioritizing oncology in 2025, as we believe this indication holds the potential for the highest value return to the Company in the form of a significant partnership and/or drug approval“
This was the most interesting statement, considering that we are going to be doing a combination with Pfizer‘s drug?
“The Company will be prioritizing oncology in 2025, as we believe this indication holds the potential for the highest value return to the Company in the form of a significant partnership and/or drug approval“
This was the most interesting statement, considering that we are going to be doing a combination with Pfizer‘s drug?
(3)
(0)Scroll down for more posts ▼
